Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Investigational drug for pulmonary hypertension may improve the quality of life for patients with scleroderma and lupus

An investigational new drug for pulmonary hypertension may improve the quality of life for thousands of patients with scleroderma, lupus, and other associated connective tissue diseases, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Antonio, Texas.

18 Oct 2004

Study underscores the relative safety of infliximab, when used properly

Rheumatoid arthritis patients receiving the recommended starting dose (3mg/kg) of infliximab (REMICADE®) have no more serious rate of infections than do patients taking methotrexate alone

18 Oct 2004

Mycophenolate mofetil is effective for managing symptoms of the most common type of lupus

Mayo Clinic investigators have found that the medication mycophenolate mofetil is effective for managing symptoms of systemic lupus erythematosus (SLE), the most common type of lupus, for patients whose SLE does not affect the kidneys.

18 Oct 2004

New treatment antibody - AMG 162 - may help prevent osteoporosis and rheumatoid arthritis

A novel treatment administered semiannually to postmenopausal women with low bone density appears to rapidly inhibit the bone resorption process, resulting in improvements in bone mineral density at 12 months

18 Oct 2004

$Strontium ranelate may reduce spinal, non-spinal, hip and other fractures in older women with osteoporosis$

Strontium ranelate may reduce spinal, non-spinal, hip and other fractures in older women with osteoporosis

Strontium ranelate, a new oral medication on the horizon, may reduce spinal, non-spinal, hip and other fractures in older women with osteoporosis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Antonio, Texas.

18 Oct 2004

People who suffer arthritis also suffer double the amount of medical costs

The expenses for medical care for those with arthritis are at least double the amount spent by those without this debilitating disease, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Antonio, Texas.

18 Oct 2004

COX-2 agents have influenced the way physicians prescribe rheumatology medication

COX-2 agents, with their perceived reduction in side effects, have contributed substantially to a dramatic increase in NSAIDs (non-steroidal anti-inflammatory drugs) prescription utilization and influenced the way physicians prescribe rheumatology medication

18 Oct 2004

Pneumococcal vaccinations help protect patients with rheumatoid arthritis against serious pneumococcal infections of the lungs, brain, blood, and ears

Rheumatoid arthritis patients have an approximately two-fold increased morbidity and mortality in infections compared to a population without the disease.

18 Oct 2004

Low dose aspirin dosages trigger the body to generate its own anti-inflammatory compounds

Researchers at Brigham and Women’s Hospital (BWH) and colleagues have demonstrated for the first time in humans in a randomized clinical trial that low-dose aspirin - dosages equivalent to one baby aspirin (81 mg) - trigger the body to generate its own anti-inflammatory compounds that help fight unwanted inflammation.

13 Oct 2004

Herbal, nutritional supplements linked to side effects ranging from dry eye to retinal hemorrhages and transient visual loss

An estimated 42 percent of Americans use herbal medicines or nutritional supplements. Many people taking these products and their physicians are unaware of the adverse reactions they can cause.

13 Oct 2004

Researchers have discovered an effective new way to treat giant cell arteritis

Mayo Clinic researchers have discovered an effective new way to treat giant cell arteritis (GCA), a debilitating cause of headaches, fatigue, muscle pain and even blindness. The findings of this research will be presented at the American College of Rheumatology Annual Scientific Meeting.

13 Oct 2004

New survey reveals continued drug price disparities across the New York State

New York State Attorney General Eliot Spitzer has announced that his office's drug price website has been expanded to include pharmacies within every county in New York State.

11 Oct 2004

Signaling pathway could be a valuable target for future drug therapies against systemic lupus erythematosus

Medical investigators at the Hospital for Special Surgery have identified an important new signaling pathway they believe could be a valuable target for scientists to aim at with future drug therapies that might one day reverse diseases such as systemic lupus erythematosus, according to a recent article published in “Nature Immunology.”

11 Oct 2004

Atheromatosis, which lies behind heart attacks, stroke, and other cardiovascular problems, has a major impact on public health

These two diseases are completely different from each other, but they do have one common denominator: inflammation. Researchers at Lund University in Sweden can now show that it might also be possible to treat them with the same drug.

10 Oct 2004

Shortage of pediatric rheumatologists often leads to improper diagnosis and treatment

More than 150,000 children in the United States are affected by rheumatic diseases such as juvenile rheumatoid arthritis, lupus, dermatomyositis, scleroderma, and systemic vasculitis.

10 Oct 2004

Aspirin might well be considered the top utility player in the medicine cabinet

This cheap over-the-counter drug can be used not only for fever, pain and arthritis, but to prevent heart attack, stroke or angina. It also may reduce the risk of colorectal cancer. Yet aspirin also has side effects worth considering, and its very accessibility may hamper its use.

8 Oct 2004

Canadian Rheumatology Association issues statement on Vioxx alternatives

The Canadian Rheumatology Association (CRA) has issued a statement to its 350 members and other interested parties, recommending alternative treatment considerations in the wake of the worldwide recall of Merck's rofecoxib, (Vioxx(R)) last week.

7 Oct 2004

Rheumatoid arthritis results from a combination of genetic susceptibility and environmental triggers

Rheumatoid arthritis (RA), like many chronic diseases of the immune system, likely results from a combination of genetic susceptibility and environmental triggers.

7 Oct 2004

Study underscores the need for improved prevention and treatment of torn knee ligaments among young female athletes

Of the more than 17 million players participating in organized soccer nationwide, 7 million are female. While offering an equal opportunity playing field for student athletes, soccer has one unfortunate gender bias: women are more susceptible to knee injury.

7 Oct 2004

18 percent of seniors with chronic conditions such as heart disease and depression skip medicines due to costs

A recent nationally representative survey of older adults finds that 18 percent of those with chronic conditions such as heart disease and depression skip some of their prescription medicines because of out-of-pocket cost pressures, and 14 percent do so at least every month.

6 Oct 2004

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Investigational drug for pulmonary hypertension may improve the quality of life for patients with scleroderma and lupus

Study underscores the relative safety of infliximab, when used properly

Mycophenolate mofetil is effective for managing symptoms of the most common type of lupus

New treatment antibody - AMG 162 - may help prevent osteoporosis and rheumatoid arthritis

Strontium ranelate may reduce spinal, non-spinal, hip and other fractures in older women with osteoporosis

People who suffer arthritis also suffer double the amount of medical costs

COX-2 agents have influenced the way physicians prescribe rheumatology medication

Pneumococcal vaccinations help protect patients with rheumatoid arthritis against serious pneumococcal infections of the lungs, brain, blood, and ears

Low dose aspirin dosages trigger the body to generate its own anti-inflammatory compounds

Herbal, nutritional supplements linked to side effects ranging from dry eye to retinal hemorrhages and transient visual loss

Researchers have discovered an effective new way to treat giant cell arteritis

New survey reveals continued drug price disparities across the New York State

Signaling pathway could be a valuable target for future drug therapies against systemic lupus erythematosus

Atheromatosis, which lies behind heart attacks, stroke, and other cardiovascular problems, has a major impact on public health

Shortage of pediatric rheumatologists often leads to improper diagnosis and treatment

Aspirin might well be considered the top utility player in the medicine cabinet

Canadian Rheumatology Association issues statement on Vioxx alternatives

Rheumatoid arthritis results from a combination of genetic susceptibility and environmental triggers

Study underscores the need for improved prevention and treatment of torn knee ligaments among young female athletes

18 percent of seniors with chronic conditions such as heart disease and depression skip medicines due to costs

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in